Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Cannabis Bioscience International Holdings Days Payable?
Cannabis Bioscience International HoldingsCBIH Days Payable is 306.73 as of Feb. 2026, which is 72% below its 10-year median of 1,098.97. The stock has 4 warning signs investors should review. Among 928 Drug Manufacturers companies, Cannabis Bioscience International Holdings ranks better than 97.95% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Bioscience International Holdings Days Payable Chart
Cannabis Bioscience International Holdings Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Bioscience International Holdings Days Payable vs Drug Manufacturers Industry
Cannabis Bioscience International Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Bioscience International Holdings (CBIH) has a Days Payable of 306.73 as of Feb. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cannabis Bioscience International Holdings and its competitors. This is 72% below median its historical median of 1,098.97. Over the past decade, Cannabis Bioscience International Holdings' Days Payable has ranged from 34.64 to 25,676.20. According to the industry distribution chart, Cannabis Bioscience International Holdings ranks #19 out of 928 companies in the Drug Manufacturers industry, placing it in the top 2%.
Is Cannabis Bioscience International Holdings' Days Payable too high?
Cannabis Bioscience International Holdings' current Days Payable of 306.73 is 72% below median its 10-year median of 1,098.97. Over the past 10 years, this metric has ranged from a low of 34.64 to a high of 25,676.20. The Drug Manufacturers industry median Days Payable is 88.39. Cannabis Bioscience International Holdings' value of 306.73 is 247% above this industry median. Based on the distribution chart, Cannabis Bioscience International Holdings ranks #19 out of 928 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Cannabis Bioscience International Holdings' Days Payable compare to SKYI and CBDY?
According to the Drug Manufacturers industry distribution chart, Cannabis Bioscience International Holdings ranks #19 out of 928 companies for Days Payable. This places Cannabis Bioscience International Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 88.39. Cannabis Bioscience International Holdings' value of 306.73 is 247% above this benchmark. Historically, Cannabis Bioscience International Holdings' own Days Payable has ranged from 34.64 to 25,676.20 over the past decade. While the company's 10-year median is 1,098.97 vs. the industry median of 88.39, Cannabis Bioscience International Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.39, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Bioscience International Holdings's current Days Payable of 306.73 is 247% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Cannabis Bioscience International Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Bioscience International Holdings's current Days Payable is 306.73, which is 72% below median its own 10-year median of 1,098.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Bioscience International Holdings stock overvalued right now?
Cannabis Bioscience International Holdings (CBIH) has a current Days Payable of 306.73. The current Days Payable is 306.73, which is 72% below median its 10-year median of 1,098.97 and 247% above the Drug Manufacturers industry median of 88.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Cannabis Bioscience International Holdings (CBIH), the current Days Payable is 306.73 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabis Bioscience International Holdings Inc operates in three main areas. Firstly, the company engages in cannabis-related research and education under the trade name Pharmacology University. Secondly, it serves as both a Sponsor and a Contract Research Organization (CRO) in clinical trials, some of which involve cannabis and CBD products, under the trade name Alpha Research Institute. Lastly, the company plans to manufacture, market, and sell CBD products branded as "VitaCookies." The majority of the company's revenue comes from clinical trial contracts, while a smaller portion is generated from cannabis-related educational classes and seminars.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBIH has been successfully added to your 
